ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BTAI BioXcel Therapeutics Inc

2.5899
-0.0001 (0.00%)
After Hours
Last Updated: 15:18:13
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
BioXcel Therapeutics Inc BTAI NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0001 0.00% 2.5899 15:18:13
Open Price Low Price High Price Close Price Previous Close
2.59 2.55 2.6314 2.55 2.59
more quote information »

Recent News

Date Time Source Heading
4/10/202406:00GLOBEBioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal..
3/25/202406:00GLOBEBioXcel Therapeutics Announces $25 Million Registered Direct..
3/15/202406:00GLOBEBioXcel Therapeutics Announces European Patent Office’s..
3/12/202406:00GLOBEBioXcel Therapeutics Reports Financial Results for the..
3/01/202406:00GLOBEBioXcel Therapeutics to Report Fourth Quarter and Full Year..
2/14/202406:00EDGAR2Form 8-K - Current report
2/13/202408:00GLOBEBioXcel Therapeutics Announces Termination of Proposed..
2/12/202411:45EDGAR2Form 8-K - Current report
2/12/202406:14GLOBEBioXcel Therapeutics Receives FDA Fast Track Designation for..
2/08/202416:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/08/202415:53EDGAR2Form 8-K - Current report
2/08/202415:01GLOBEBioXcel Therapeutics Announces Proposed Public Offering
2/08/202406:08EDGAR2Form 8-K - Current report
2/06/202406:00GLOBEBioXcel Therapeutics Announces Completion of Patient..
2/05/202406:00GLOBEBioXcel Therapeutics Announces USPTO’s Allowance of Patent..
1/22/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
1/12/202415:16EDGAR2Form S-3 - Registration statement under Securities Act of..
12/18/202315:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/18/202315:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/18/202315:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/18/202306:22EDGAR2Form 8-K - Current report
12/12/202306:00EDGAR2Form 8-K - Current report
12/12/202306:00GLOBEBioXcel Therapeutics Hosting Virtual Neuroscience R&D Day..
12/11/202306:00GLOBEBioXcel Therapeutics Strengthens Clinical Development..
12/06/202306:00EDGAR2Form 8-K - Current report
11/30/202306:00GLOBEBioXcel Therapeutics to Host Virtual Neuroscience R&D Day on..
11/13/202310:59EDGAR2Form RW WD - Withdrawal of Registration Withdrawal Request
11/13/202309:23EDGAR2Form RW - Registration Withdrawal Request
11/08/202306:00GLOBEBioXcel Therapeutics Reports Positive Overall Survival..
11/06/202306:00GLOBEBioXcel Therapeutics Announces Update on NIDA-funded Trial..
11/02/202305:01EDGAR2Form S-3 - Registration statement under Securities Act of..
10/31/202306:00GLOBEBioXcel Therapeutics to Report Third Quarter 2023 Financial..
10/30/202306:00GLOBEBioXcel Therapeutics Receives Permanent J-Code for IGALMI™..
10/25/202309:30APSStrong Open For Biotech Shares Following Phase 3 Comments
10/25/202306:00GLOBEBioXcel Therapeutics Announces Positive Findings from..
10/19/202315:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/10/202306:06EDGAR2Form 8-K - Current report
10/10/202306:00GLOBEBioXcel Therapeutics Reports Positive Overall Survival..
10/04/202306:05EDGAR2Form 8-K - Current report
10/04/202306:00GLOBEBioXcel Therapeutics Provides Update on Recent Developments..
9/25/202316:07EDGAR2Form 8-K - Current report
9/20/202310:21EDGAR2Form 144 - Report of proposed sale of securities
9/20/202310:15EDGAR2Form 144 - Report of proposed sale of securities
9/19/202307:00EDGAR2Form 8-K - Current report
9/18/202315:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/18/202315:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/18/202315:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/12/202306:00EDGAR2Form 8-K - Current report
9/07/202306:00EDGAR2Form 8-K - Current report
8/29/202304:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..

Your Recent History

Delayed Upgrade Clock